Wall Street analyst estimates for Anteris Technologies Global Corp. (AVR): consensus price target, buy/hold/sell recommendations and forecasts for revenue, EPS and EBITDA for the upcoming fiscal years.
Anteris Technologies Global Corp. is a structural heart innovator dedicated to discovering, developing, and bringing to market medical devices that enhance the well-being of patients grappling with aortic stenosis. The company's premier offering is the DurAVR transcatheter heart valve system, a pioneering transcatheter aortic valve engineered to treat aortic stenosis by precisely emulating the performance of a healthy human aortic valve.
Analyst Consensus
| Strong Buy | 0 |
| Buy | 2 |
| Hold | 0 |
| Sell | 0 |
| Strong Sell | 0 |
| Total analysts | 2 |
| Avg rating (1-5) | 1.00 |
Valuation Ratios
| Price / Book | 3.24 |
| EV / EBITDA | -5.56 |
| Dividend Yield | 0.00% |
Income Statement (10y)
| Year | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|
| Revenue | $5.5M | $5.8M | $3.2M | $2.7M | $2.7M | $1.9M |
| Cost of Revenue | $2.1M | $3.9M | $2.9M | $1.9M | $1.4M | $2.2M |
| Gross Profit | $3.4M | $1.9M | $298383 | $876800 | $1.3M | -$317000 |
| Research & Development | $3.6M | $10.0M | $17.6M | $31.0M | $51.5M | $69.1M |
| Selling, General & Admin | $2.6M | $9.1M | $15.2M | $17.0M | 0 | $24.5M |
| Operating Expenses | $16.6M | $18.8M | $31.4M | $49.0M | $79.6M | $93.6M |
| Operating Income | -$13.3M | -$16.9M | -$31.1M | -$48.1M | -$78.4M | -$93.9M |
| EBITDA | -$14.1M | -$15.5M | -$29.1M | -$45.5M | -$74.4M | -$92.5M |
| Interest Expense | $300641 | $1.0M | $648709 | $67089 | $82000 | $73000 |
| Pre-tax Income | -$11.8M | -$17.2M | -$30.6M | -$46.8M | -$76.0M | -$94.2M |
| Income Tax | 0 | 0 | 0 | 0 | 0 | 0 |
| Net Income | -$11.8M | -$17.2M | -$30.6M | -$46.0M | -$76.3M | -$94.1M |
| EPS | $-0.33 | $-0.48 | $-0.85 | $-1.28 | $-3.77 | $-2.55 |
| EPS (Diluted) | $-0.33 | $-0.48 | $-0.85 | $-1.28 | $-3.77 | $-2.55 |
| Shares Outstanding (Diluted) | $35.9M | $35.9M | $35.9M | $35.9M | $20.3M | $36.9M |
Price
| Price | $8.42 |
| Market Cap | $819M |
| Exchange | NASDAQ |
| Country | US |
Related companies: ANIK · ARAY · ATLN · CYBN · LNSR · LUCD · MXCT
Explore sector: Healthcare · Medical - Devices
More sections of AVR: Overview · Financials · Valuation · Statistics · Technical · Ownership · News · Events
Discover more: Radar — undervalued stock signals · Investment Academy — learn to analyze stocks